Phase 3 Schizophrenia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are male or female, between 18 and 65 years old
• You are able to read, understand, and sign a consent form approved by an ethics committee before any screening begins
• You have been diagnosed with schizophrenia

Who may not be able to join:

• You have a history of not responding, or barely responding, to at least 2 different antipsychotic medications taken for 28 days or more at the highest dose you could tolerate
• You have ever taken the medication clozapine
• You have had electroconvulsive therapy (a treatment using electrical stimulation) for schizophrenia in the past 5 years
• You have never previously been treated for schizophrenia
• Your main diagnosis is something other than schizophrenia, or another condition is more responsible for your current symptoms
• You have a current diagnosis of a psychotic disorder other than schizophrenia, or symptoms believed to be caused by substance misuse
• You have had a moderate-to-severe problem with substance use (not including caffeine or nicotine) in the past 6 months
• You have a history of traumatic brain injury causing ongoing thinking difficulties, Alzheimer's disease, dementia, or another long-term brain or nervous system condition
• You have an intellectual disability that would make it difficult to take part in the study
• You have a current primary diagnosis of another mental health condition, such as schizoaffective disorder, major depression, PTSD, OCD, bipolar episodes, panic disorder, or certain personality disorders (confirm with trial site)
• You are currently taking antipsychotic medication within the screening period (at least 3 days before the study baseline and throughout the study)
• You have taken certain medications within 28 days before the study starts, including MAO inhibitors, stimulants, or specific drugs that strongly affect how the body processes medications (confirm with trial site for the full list)
• You have received a long-acting injectable antipsychotic medication within a certain timeframe before the study starts (confirm with trial site)
• A urine drug test shows the presence of certain substances, such as amphetamines, cocaine, opiates, or others, at a level meeting criteria for moderate-to-severe misuse

Important: Always verify eligibility with the trial site directly before applying.